<b>Cooley advises Atara Biotherapeutics in $207M follow-on offering</b>
<p/>
Cooley LLP advised Atara Biotherapeutics Inc., a San Francisco-based biopharmaceutical
company that develops therapies for patients with severe and life threatening diseases,
in its $207 million fo...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In